메뉴 건너뛰기




Volumn 132, Issue 11, 2009, Pages 3152-3164

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

Author keywords

Cannabinoid; Excitotoxicity; Huntington's disease; Microglia; Neurodegeneration

Indexed keywords

4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; GANCICLOVIR; GLIAL FIBRILLARY ACIDIC PROTEIN; HUNTINGTIN; MINOCYCLINE; PRS 486; PRS 639; QUINOLINIC ACID; THYMIDINE KINASE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; HD PROTEIN, HUMAN; NERVE PROTEIN; NEUROPROTECTIVE AGENT; NUCLEAR PROTEIN;

EID: 70350697391     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp239     Document Type: Article
Times cited : (325)

References (49)
  • 1
    • 32544441379 scopus 로고    scopus 로고
    • The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells
    • Aguado T, Palazuelos J, Monory K, Stella N, Cravatt B, Lutz B, et al. The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J Neurosci 2006; 26: 155161.
    • (2006) J Neurosci , vol.26 , pp. 155161
    • Aguado, T.1    Palazuelos, J.2    Monory, K.3    Stella, N.4    Cravatt, B.5    Lutz, B.6
  • 2
    • 33847420442 scopus 로고    scopus 로고
    • Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis
    • Benito C, Romero JP, Tolon RM, Clemente D, Docagne F, Hillard CJ, et al. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci 2007; 27: 2396402.
    • (2007) J Neurosci , vol.27 , pp. 2396402
    • Benito, C.1    Romero, J.P.2    Tolon, R.M.3    Clemente, D.4    Docagne, F.5    Hillard, C.J.6
  • 3
    • 49249089029 scopus 로고    scopus 로고
    • A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
    • Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J Exp Med 2008; 205: 186977.
    • (2008) J Exp Med , vol.205 , pp. 186977
    • Bjorkqvist, M.1    Wild, E.J.2    Thiele, J.3    Silvestroni, A.4    Andre, R.5    Lahiri, N.6
  • 4
    • 33845768784 scopus 로고    scopus 로고
    • Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms
    • Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007; 8: 5769.
    • (2007) Nat Rev Neurosci , vol.8 , pp. 5769
    • Block, M.L.1    Zecca, L.2    Hong, J.S.3
  • 5
    • 0034685707 scopus 로고    scopus 로고
    • Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor
    • Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 2000; 396: 1419.
    • (2000) Eur J Pharmacol , vol.396 , pp. 1419
    • Buckley, N.E.1    McCoy, K.L.2    Mezey, E.3    Bonner, T.4    Zimmer, A.5    Felder, C.C.6
  • 6
    • 4444350918 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephaliner-gic neuronal degeneration in Huntington's disease
    • Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, et al. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephaliner-gic neuronal degeneration in Huntington's disease. J Neurosci 2004; 24: 772739.
    • (2004) J Neurosci , vol.24 , pp. 772739
    • Canals, J.M.1    Pineda, J.R.2    Torres-Peraza, J.F.3    Bosch, M.4    Martin-Ibanez, R.5    Munoz, M.T.6
  • 7
    • 28644433087 scopus 로고    scopus 로고
    • Normal huntingtin function: An alternative approach to Huntington's disease
    • Cattaneo E, Zuccato C, Tartari M. Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci 2005; 6: 91930.
    • (2005) Nat Rev Neurosci , vol.6 , pp. 91930
    • Cattaneo, E.1    Zuccato, C.2    Tartari, M.3
  • 8
    • 34848897836 scopus 로고    scopus 로고
    • The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis
    • Centonze D, Bari M, Rossi S, Prosperetti C, Furlan R, Fezza F, et al. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain 2007; 130: 254353.
    • (2007) Brain , vol.130 , pp. 254353
    • Centonze, D.1    Bari, M.2    Rossi, S.3    Prosperetti, C.4    Furlan, R.5    Fezza, F.6
  • 9
    • 20444367602 scopus 로고    scopus 로고
    • Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice
    • Centonze D, Rossi S, Prosperetti C, Tscherter A, Bernardi G, Maccarrone M, et al. Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. Biol Psychiatry 2005; 57: 15839.
    • (2005) Biol Psychiatry , vol.57 , pp. 15839
    • Centonze, D.1    Rossi, S.2    Prosperetti, C.3    Tscherter, A.4    Bernardi, G.5    MacCarrone, M.6
  • 10
    • 0037322570 scopus 로고    scopus 로고
    • Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease
    • Cepeda C, Hurst RS, Calvert CR, Hernandez-Echeagaray E, Nguyen OK, Jocoy E, et al. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci 2003; 23: 9619.
    • (2003) J Neurosci , vol.23 , pp. 9619
    • Cepeda, C.1    Hurst, R.S.2    Calvert, C.R.3    Hernandez-Echeagaray, E.4    Nguyen, O.K.5    Jocoy, E.6
  • 11
    • 0033912716 scopus 로고    scopus 로고
    • Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
    • Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 2000; 6: 797801.
    • (2000) Nat Med , vol.6 , pp. 797801
    • Chen, M.1    Ona, V.O.2    Li, M.3    Ferrante, R.J.4    Fink, K.B.5    Zhu, S.6
  • 12
    • 41549117229 scopus 로고    scopus 로고
    • Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes
    • Chou SY, Weng JY, Lai HL, Liao F, Sun SH, Tu PH, et al. Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes. J Neurosci 2008; 28: 327790.
    • (2008) J Neurosci , vol.28 , pp. 327790
    • Chou, S.Y.1    Weng, J.Y.2    Lai, H.L.3    Liao, F.4    Sun, S.H.5    Tu, P.H.6
  • 13
    • 33947583201 scopus 로고    scopus 로고
    • Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation
    • Docagne F, Muneton V, Clemente D, Ali C, Loria F, Correa F, et al. Excitotoxicity in a chronic model of multiple sclerosis: neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation. Mol Cell Neurosci 2007; 34: 55161.
    • (2007) Mol Cell Neurosci , vol.34 , pp. 55161
    • Docagne, F.1    Muneton, V.2    Clemente, D.3    Ali, C.4    Loria, F.5    Correa, F.6
  • 14
    • 29544446576 scopus 로고    scopus 로고
    • The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells
    • Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, et al. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 2006; 49: 6779.
    • (2006) Neuron , vol.49 , pp. 6779
    • Eljaschewitsch, E.1    Witting, A.2    Mawrin, C.3    Lee, T.4    Schmidt, P.M.5    Wolf, S.6
  • 17
    • 45149107487 scopus 로고    scopus 로고
    • Mechanisms of neurodegeneration in Huntington's disease
    • Gil JM, Rego AC. Mechanisms of neurodegeneration in Huntington's disease. Eur J Neurosci 2008; 27: 280320.
    • (2008) Eur J Neurosci , vol.27 , pp. 280320
    • Gil, J.M.1    Rego, A.C.2
  • 18
    • 0034081681 scopus 로고    scopus 로고
    • The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease
    • Glass M, Dragunow M, Faull RL. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience 2000; 97: 50519.
    • (2000) Neuroscience , vol.97 , pp. 50519
    • Glass, M.1    Dragunow, M.2    Faull, R.L.3
  • 20
    • 46849097142 scopus 로고    scopus 로고
    • NMDA receptors in clinical neurology: Excitatory times ahead
    • Kalia LV, Kalia SK, Salter MW. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol 2008; 7: 74255.
    • (2008) Lancet Neurol , vol.7 , pp. 74255
    • Kalia, L.V.1    Kalia, S.K.2    Salter, M.W.3
  • 21
    • 51349141952 scopus 로고    scopus 로고
    • Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
    • Katona I, Freund TF. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 2008; 14: 92330.
    • (2008) Nat Med , vol.14 , pp. 92330
    • Katona, I.1    Freund, T.F.2
  • 22
    • 33846908287 scopus 로고    scopus 로고
    • Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
    • Kreitzer AC, Malenka RC. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 2007; 445: 6437.
    • (2007) Nature , vol.445 , pp. 6437
    • Kreitzer, A.C.1    Malenka, R.C.2
  • 23
    • 0037040530 scopus 로고    scopus 로고
    • Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB(1) receptors in the basal ganglia of a transgenic model of Huntington's disease
    • Lastres-Becker I, Berrendero F, Lucas JJ, Martin-Aparicio E, Yamamoto A, Ramos JA, et al. Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB(1) receptors in the basal ganglia of a transgenic model of Huntington's disease. Brain Res 2002; 929: 23642.
    • (2002) Brain Res , vol.929 , pp. 23642
    • Lastres-Becker, I.1    Berrendero, F.2    Lucas, J.J.3    Martin-Aparicio, E.4    Yamamoto, A.5    Ramos, J.A.6
  • 24
    • 43449086380 scopus 로고    scopus 로고
    • Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration
    • Lepore AC, Dejea C, Carmen J, Rauck B, Kerr DA, Sofroniew MV, et al. Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration. Exp Neurol 2008; 211: 42332.
    • (2008) Exp Neurol , vol.211 , pp. 42332
    • Lepore, A.C.1    Dejea, C.2    Carmen, J.3    Rauck, B.4    Kerr, D.A.5    Sofroniew, M.V.6
  • 25
    • 35549006420 scopus 로고    scopus 로고
    • Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease
    • Lobsiger CS, Cleveland DW. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 2007; 10: 135560.
    • (2007) Nat Neurosci , vol.10 , pp. 135560
    • Lobsiger, C.S.1    Cleveland, D.W.2
  • 26
    • 34047139505 scopus 로고    scopus 로고
    • The endocannabinoid pathway in Huntington's disease: A comparison with other neurodegenerative diseases
    • Maccarrone M, Battista N, Centonze D. The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases. Prog Neurobiol 2007; 81: 34979.
    • (2007) Prog Neurobiol , vol.81 , pp. 34979
    • MacCarrone, M.1    Battista, N.2    Centonze, D.3
  • 27
    • 33144480327 scopus 로고    scopus 로고
    • Cannabinoid receptors as therapeutic targets
    • Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 2006; 46: 10122.
    • (2006) Annu Rev Pharmacol Toxicol , vol.46 , pp. 10122
    • MacKie, K.1
  • 28
    • 16044373842 scopus 로고    scopus 로고
    • Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
    • Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493506.
    • (1996) Cell , vol.87 , pp. 493506
    • Mangiarini, L.1    Sathasivam, K.2    Seller, M.3    Cozens, B.4    Harper, A.5    Hetherington, C.6
  • 29
    • 26844448746 scopus 로고    scopus 로고
    • Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
    • Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 2005; 95: 43745.
    • (2005) J Neurochem , vol.95 , pp. 43745
    • Maresz, K.1    Carrier, E.J.2    Ponomarev, E.D.3    Hillard, C.J.4    Dittel, B.N.5
  • 30
    • 34147165471 scopus 로고    scopus 로고
    • Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB(1) on neurons and CB(2) on auto-reactive T cells
    • Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, et al. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB(1) on neurons and CB(2) on auto-reactive T cells. Nat Med 2007; 13: 4927.
    • (2007) Nat Med , vol.13 , pp. 4927
    • Maresz, K.1    Pryce, G.2    Ponomarev, E.D.3    Marsicano, G.4    Croxford, J.L.5    Shriver, L.P.6    Al, E.7
  • 31
    • 11244306357 scopus 로고    scopus 로고
    • Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice
    • McCaw EA, Hu H, Gomez GT, Hebb AL, Kelly ME, Denovan-Wright EM. Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice. Eur J Biochem 2004; 271: 490920.
    • (2004) Eur J Biochem , vol.271 , pp. 490920
    • McCaw, E.A.1    Hu, H.2    Gomez, G.T.3    Hebb, A.L.4    Kelly, M.E.5    Denovan-Wright, E.M.6
  • 32
    • 38349086382 scopus 로고    scopus 로고
    • CB2 receptor-mediated migration of immune cells: It can go either way
    • Miller AM, Stella N. CB2 receptor-mediated migration of immune cells: it can go either way. Br J Pharmacol 2008; 153: 299308.
    • (2008) Br J Pharmacol , vol.153 , pp. 299308
    • Miller, A.M.1    Stella, N.2
  • 33
    • 33749508895 scopus 로고    scopus 로고
    • Essential protective roles of reactive astrocytes in traumatic brain injury
    • Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006; 129: 276172.
    • (2006) Brain , vol.129 , pp. 276172
    • Myer, D.J.1    Gurkoff, G.G.2    Lee, S.M.3    Hovda, D.A.4    Sofroniew, M.V.5
  • 34
    • 40849100074 scopus 로고    scopus 로고
    • Endocannabinoids mediate neuron-astrocyte communication
    • Navarrete M, Araque A. Endocannabinoids mediate neuron-astrocyte communication. Neuron 2008; 57: 88393.
    • (2008) Neuron , vol.57 , pp. 88393
    • Navarrete, M.1    Araque, A.2
  • 35
    • 33745919498 scopus 로고    scopus 로고
    • Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury
    • Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 2006; 12: 82934.
    • (2006) Nat Med , vol.12 , pp. 82934
    • Okada, S.1    Nakamura, M.2    Katoh, H.3    Miyao, T.4    Shimazaki, T.5    Ishii, K.6
  • 36
  • 37
    • 45149123400 scopus 로고    scopus 로고
    • The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: Involvement in the pathogenesis of an animal model of multiple sclerosis
    • Palazuelos J, Davoust N, Julien B, Hatterer E, Aguado T, Mechoulam R, et al. The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. J Biol Chem 2008; 283: 133209.
    • (2008) J Biol Chem , Issue.283 , pp. 133209
    • Palazuelos, J.1    Davoust, N.2    Julien, B.3    Hatterer, E.4    Aguado, T.5    Mechoulam, R.6
  • 38
    • 33749512169 scopus 로고    scopus 로고
    • The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum
    • Pintor A, Tebano MT, Martire A, Grieco R, Galluzzo M, Scattoni ML, et al. The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum. Neuropharmacology 2006; 51: 100412.
    • (2006) Neuropharmacology , vol.51 , pp. 100412
    • Pintor, A.1    Tebano, M.T.2    Martire, A.3    Grieco, R.4    Galluzzo, M.5    Scattoni, M.L.6
  • 40
    • 14244264502 scopus 로고    scopus 로고
    • Prevention of Alzheimer's disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation
    • Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 2005; 25: 190413.
    • (2005) J Neurosci , vol.25 , pp. 190413
    • Ramirez, B.G.1    Blazquez, C.2    Gomez Del Pulgar, T.3    Guzman, M.4    De Ceballos, M.L.5
  • 41
    • 0028071467 scopus 로고
    • Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidus
    • Richfield EK, Herkenham M. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann Neurol 1994; 36: 57784.
    • (1994) Ann Neurol , vol.36 , pp. 57784
    • Richfield, E.K.1    Herkenham, M.2
  • 42
    • 67649885952 scopus 로고    scopus 로고
    • Cannabinoid CB(2) receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease
    • Sagredo O, Gonzalez S, Aroyo I, Pazos MR, Benito C, Lastres-Becker I, et al. Cannabinoid CB(2) receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. Glia 2008; 57: 115467.
    • (2008) Glia , vol.57 , pp. 115467
    • Sagredo, O.1    Gonzalez, S.2    Aroyo, I.3    Pazos, M.R.4    Benito, C.5    Lastres-Becker, I.6    Al, E.7
  • 44
    • 29144460321 scopus 로고    scopus 로고
    • Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
    • Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 2005; 171: 100112.
    • (2005) J Cell Biol , vol.171 , pp. 100112
    • Shin, J.Y.1    Fang, Z.H.2    Yu, Z.X.3    Wang, C.E.4    Li, S.H.5    Li, X.J.6
  • 45
    • 33947278309 scopus 로고    scopus 로고
    • The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
    • Shoemaker JL, Seely KA, Reed RL, Crow JP, Prather PL. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J Neurochem 2007; 101: 8798.
    • (2007) J Neurochem , vol.101 , pp. 8798
    • Shoemaker, J.L.1    Seely, K.A.2    Reed, R.L.3    Crow, J.P.4    Prather, P.L.5
  • 46
    • 34447520021 scopus 로고    scopus 로고
    • Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease
    • Simmons DA, Casale M, Alcon B, Pham N, Narayan N, Lynch G. Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia 2007; 55: 107484.
    • (2007) Glia , vol.55 , pp. 107484
    • Simmons, D.A.1    Casale, M.2    Alcon, B.3    Pham, N.4    Narayan, N.5    Lynch, G.6
  • 47
    • 34447636065 scopus 로고    scopus 로고
    • Microglial activation in presymptomatic Huntington's disease gene carriers
    • Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, et al. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 2007; 130: 175966.
    • (2007) Brain , vol.130 , pp. 175966
    • Tai, Y.F.1    Pavese, N.2    Gerhard, A.3    Tabrizi, S.J.4    Barker, R.A.5    Brooks, D.J.6
  • 48
    • 0041335559 scopus 로고    scopus 로고
    • Minocycline inhibits caspase-independent and-dependent mito-chondrial cell death pathways in models of Huntington's disease
    • Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, et al. Minocycline inhibits caspase-independent and-dependent mito-chondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci USA 2003; 100: 104837.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 104837
    • Wang, X.1    Zhu, S.2    Drozda, M.3    Zhang, W.4    Stavrovskaya, I.G.5    Cattaneo, E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.